{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:41:23Z","timestamp":1792428083029,"version":"4.5.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It is widely recognized that dysregulated mineral balance, in the context of disease, has negative health consequences. However, growing evidence shows that imbalances in mineral homeostasis from a sustained high dietary intake of inorganic phosphate\/phosphorus (Pi), even when kidney function remains clinically normal, can also cause serious health problems, including bone disease. Western-style diets, which commonly include added Pi salts, contribute significantly to the issue. Despite this, investigations into therapeutic strategies to counter these effects in the absences of disease are limited. This study aimed to determine whether clinically used pharmacologic and nutritional interventions could regulate mineral homeostasis and prevent bone loss while correcting the systemic consequences of chronic high dietary Pi intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthy mice were fed diets with high (HPD), normal (NPD), or low (LPD) levels of Pi additives and constant calcium (Ca). Additional groups were treated with HPD and supplemented with Vitamin D, Lanthanum Carbonate, Cinacalcet, Zoledronic acid, or a strategy of balancing dietary Ca:Pi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The therapies that partially or fully corrected serum Pi levels and homeostatic factors, interestingly, corrected the increase in cortical porosity but did not correct the HPD-induced decrease in cortical or trabecular bone volume. Only Zoledronic acid successfully restored the bone volume lost due to HPD but exacerbated the HPD increase in cortical porosity. Surprisingly, many of the treatments generated an inflammatory response in kidney in the context of HPD, suggesting that they can have harmful side effects in the absence of overt kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work advances the understanding of the health impacts of Pi additives which are common in ultra-processed foods and common in the Western style diet. Specifically, the results produce clinically relevant findings that simply controlling serum Pi and\/or Ca levels or Pi responsive endocrine factors such as FGF23, PTH, and osteopontin are not sufficient to block the negative impacts of chronic high dietary Pi consumption on the skeleton. Further, therapeutic strategies to control serum Pi have an impact on the kidneys in the context of high dietary Pi intake.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08624-x","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:53:15Z","timestamp":1784685195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correcting serum phosphate homeostasis does not alleviate the health dangers of high phosphate consumption"],"prefix":"10.1186","volume":"24","author":[{"given":"Jamie L.","family":"Arnst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"D. Alappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Viggeswarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-4095","authenticated-orcid":false,"suffix":"Jr.","given":"George R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"6","key":"8624_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MED.0b013e32834041d4","volume":"17","author":"R Lee","year":"2010","unstructured":"Lee R, Weber TJ. Disorders of phosphorus homeostasis. Curr Opin Endocrinol Diabetes Obes. 2010;17(6):561\u201367. https:\/\/doi.org\/10.1097\/MED.0b013e32834041d4.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"8624_CR2","doi-asserted-by":"publisher","first-page":"153865","DOI":"10.1016\/j.metabol.2019.01.006","volume":"103","author":"J Bacchetta","year":"2020","unstructured":"Bacchetta J, Bardet C, Prie D. Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism. 2020;103:153865. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006.","journal-title":"Metabolism"},{"issue":"11","key":"8624_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrneph.2013.147","volume":"9","author":"J Silver","year":"2013","unstructured":"Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013;9(11):641\u201349. https:\/\/doi.org\/10.1038\/nrneph.2013.147.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"8624_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520\u201328.","journal-title":"J Am Soc Nephrol"},{"key":"8624_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cca.2017.09.005","volume":"474","author":"Y Hou","year":"2017","unstructured":"Hou Y, Li X, Sun L, Qu Z, Jiang L, Du Y. Phosphorus and mortality risk in end-stage renal disease: a meta-analysis. Clin Chim Acta. 2017;474:108\u201313. https:\/\/doi.org\/10.1016\/j.cca.2017.09.005.","journal-title":"Clin Chim Acta"},{"key":"8624_CR6","doi-asserted-by":"publisher","unstructured":"O\u2019Connor LE, Herrick KA, Papier K. Handle with care: challenges associated with ultra-processed foods research. Int J Epidemiol. 2024;53(5). https:\/\/doi.org\/10.1093\/ije\/dyae106.","DOI":"10.1093\/ije\/dyae106"},{"issue":"1","key":"8624_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41413-020-00127-9","volume":"9","author":"J Zaretsky","year":"2021","unstructured":"Zaretsky J, Griess-Fishheimer S, Carmi A, Travinsky Shmul T, Ofer L, Sinai T, et al. Ultra-processed food targets bone quality via endochondral ossification. Bone Res. 2021;9(1):14. https:\/\/doi.org\/10.1038\/s41413-020-00127-9.","journal-title":"Bone Res"},{"issue":"5","key":"8624_CR8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/advances\/nmab049","volume":"12","author":"F Juul","year":"2021","unstructured":"Juul F, Vaidean G, Parekh N. Ultra-processed foods and cardiovascular diseases: potential mechanisms of action. Adv Nutr. 2021;12(5):1673\u201380. https:\/\/doi.org\/10.1093\/advances\/nmab049.","journal-title":"Adv Nutr"},{"issue":"16","key":"8624_CR9","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.3390\/nu15163510","volume":"15","author":"MS Calvo","year":"2023","unstructured":"Calvo MS, Dunford EK, Uribarri J. Industrial use of phosphate food additives: a mechanism linking ultra-processed food intake to cardiorenal disease risk? Nutrients. 2023;15(16):3510. https:\/\/doi.org\/10.3390\/nu15163510.","journal-title":"Nutrients"},{"issue":"8","key":"8624_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00424-022-02691-x","volume":"474","author":"I Rubio-Aliaga","year":"2022","unstructured":"Rubio-Aliaga I, Krapf R. Phosphate intake, hyperphosphatemia, and kidney function. Pflugers Arch - Eur J Physiol. 2022;474(8):935\u201347. https:\/\/doi.org\/10.1007\/s00424-022-02691-x.","journal-title":"Pflugers Arch - Eur J Physiol"},{"issue":"5","key":"8624_CR11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1172\/JCI114043","volume":"83","author":"AA Portale","year":"1989","unstructured":"Portale AA, Halloran BP, Morris RC Jr. Physiologic regulation of the serum concentration of 1, 25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest. 1989;83(5):1494\u201399. https:\/\/doi.org\/10.1172\/JCI114043.","journal-title":"J Clin Invest"},{"issue":"12","key":"8624_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","volume":"70","author":"Y Nishida","year":"2006","unstructured":"Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006;70(12):2141\u201347. https:\/\/doi.org\/10.1038\/sj.ki.5002000.","journal-title":"Kidney Int"},{"key":"8624_CR13","doi-asserted-by":"publisher","first-page":"114305","DOI":"10.1016\/j.bcp.2020.114305","volume":"183","author":"JL Arnst","year":"2021","unstructured":"Arnst JL, Beck GR Jr. Modulating phosphate consumption, a novel therapeutic approach for the control of cancer cell proliferation and tumorigenesis. Biochemical Pharmacol. 2021;183:114305. https:\/\/doi.org\/10.1016\/j.bcp.2020.114305.","journal-title":"Biochemical Pharmacol"},{"issue":"9","key":"8624_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/jn\/123.9.1627","volume":"123","author":"MS Calvo","year":"1993","unstructured":"Calvo MS. Dietary phosphorus, calcium metabolism and bone. J Nutr. 1993;123(9):1627\u201333. https:\/\/doi.org\/10.1093\/jn\/123.9.1627.","journal-title":"J Nutr"},{"issue":"4","key":"8624_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1017\/S0007114507831783","volume":"99","author":"VE Kemi","year":"2008","unstructured":"Kemi VE, Karkkainen MUM, Karp HJ, Laitinen KAE, Lamberg-Allardt CJE. Increased calcium intake does not completely counteract the effects of increased phosphorus intake on bone: an acute dose\u2013response study in healthy females. Br J nutr. 2008;99(4):832\u201339. https:\/\/doi.org\/10.1017\/S0007114507831783.","journal-title":"Br J nutr"},{"issue":"9","key":"8624_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/102.9.1133","volume":"102","author":"HH Draper","year":"1972","unstructured":"Draper HH, Sie TL, Bergan JG. Osteoporosis in aging rats induced by high phosphorus diets. J Nutr. 1972;102(9):1133\u201341. https:\/\/doi.org\/10.1093\/jn\/102.9.1133.","journal-title":"J Nutr"},{"issue":"7\u20138","key":"8624_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0899-9007(00)00313-0","volume":"16","author":"MS Calvo","year":"2000","unstructured":"Calvo MS. Dietary considerations to prevent loss of bone and renal function. Nutrition. 2000;16(7\u20138):564\u201366. https:\/\/doi.org\/10.1016\/S0899-9007(00)00313-0.","journal-title":"Nutrition"},{"key":"8624_CR18","doi-asserted-by":"publisher","unstructured":"Calvo MS, Park YK. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr. 1996;126(4):1168S\u201380. https:\/\/doi.org\/10.1093\/jn\/126.suppl_4.1168S.","DOI":"10.1093\/jn\/126.suppl_4.1168S"},{"issue":"11","key":"8624_CR19","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2015-2279","volume":"100","author":"OM Gutierrez","year":"2015","unstructured":"Gutierrez OM, Luzuriaga-McPherson A, Lin Y, Gilbert LC, Ha SW, Beck GR Jr. Impact of phosphorus-based food additives on bone and mineral metabolism. J Clin Endocr Metab. 2015;100(11):4264\u201371. https:\/\/doi.org\/10.1210\/jc.2015-2279.","journal-title":"J Clin Endocr Metab"},{"key":"8624_CR20","doi-asserted-by":"publisher","unstructured":"Roberts JL, Yu M, Viggeswarapu M, Arnst JL, Pacifici R, Beck GR Jr. Dietary phosphorus consumption alters T cell populations, cytokine production, and bone volume in mice. JCI Insight. 2023;8(10). https:\/\/doi.org\/10.1172\/jci.insight.154729.","DOI":"10.1172\/jci.insight.154729"},{"issue":"7","key":"8624_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jnutbio.2005.09.001","volume":"17","author":"MM Huttunen","year":"2006","unstructured":"Huttunen MM, Pietila PE, Viljakainen HT, Lamberg-Allardt CJE. Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats. J Nutr Biochem. 2006;17(7):479\u201384. https:\/\/doi.org\/10.1016\/j.jnutbio.2005.09.001.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"8624_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1359\/jbmr.061009","volume":"22","author":"MM Huttunen","year":"2007","unstructured":"Huttunen MM, Tillman I, Viljakainen HT, Tuukkanen J, Peng Z, Pekkinen M, et al. High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Min Res. 2007;22(1):83\u201392.","journal-title":"J Bone Min Res"},{"issue":"5","key":"8624_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1271\/bbb.69.1025","volume":"69","author":"M Koshihara","year":"2005","unstructured":"Koshihara M, Katsumata S, Uehara M, Suzuki K. Effects of dietary phosphorus intake on bone mineralization and calcium absorption in adult female rats. Biosci Biotechnol Biochem. 2005;69(5):1025\u201328. https:\/\/doi.org\/10.1271\/bbb.69.1025.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"8624_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1079\/BJN20061838","volume":"96","author":"VE Kemi","year":"2006","unstructured":"Kemi VE, Karkkainen MUM, Lamberg-Allardt CJE. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J nutr. 2006;96(3):545\u201352. https:\/\/doi.org\/10.1079\/BJN20061838.","journal-title":"Br J nutr"},{"issue":"9","key":"8624_CR25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/jn\/102.9.1143","volume":"102","author":"GV Krishnarao","year":"1972","unstructured":"Krishnarao GV, Draper HH. Influence of dietary phosphate on bone resorption in senescent mice. J Nutr. 1972;102(9):1143\u201345. https:\/\/doi.org\/10.1093\/jn\/102.9.1143.","journal-title":"J Nutr"},{"issue":"6","key":"8624_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/jn\/110.6.1161","volume":"110","author":"RR Bell","year":"1980","unstructured":"Bell RR, Tzeng DY, Draper HH. Long-term effects of calcium, phosphorus and forced exercise on the bones of mature mice. J Nutr. 1980;110(6):1161\u201368. https:\/\/doi.org\/10.1093\/jn\/110.6.1161.","journal-title":"J Nutr"},{"issue":"1","key":"8624_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jn\/92.1.30","volume":"92","author":"BG Shah","year":"1967","unstructured":"Shah BG, Krishnarao GV, Draper HH. The relationship of Ca and P nutrition during adult life and osteoporosis in aged mice. J Nutr. 1967;92(1):30\u201342. https:\/\/doi.org\/10.1093\/jn\/92.1.30.","journal-title":"J Nutr"},{"key":"8624_CR28","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.jnutbio.2020.108374","volume":"80","author":"OM Gutierrez","year":"2020","unstructured":"Gutierrez OM, Porter AK, Viggeswarapu M, Roberts JL, Beck GR Jr. Effects of phosphorus and calcium to phosphorus consumption ratio on mineral metabolism and cardiometabolic health. J Nutr Biochem. 2020;80:108374. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108374.","journal-title":"J Nutr Biochem"},{"key":"8624_CR29","doi-asserted-by":"publisher","first-page":"575932","DOI":"10.1155\/2014\/575932","volume":"2014","author":"S Katsumata","year":"2014","unstructured":"Katsumata S, Matsuzaki H, Katsumata-Tsuboi R, Uehara M, Suzuki K. Effects of high phosphorus diet on bone metabolism-related gene expression in young and aged mice. J Nutr Metab. 2014;2014:575932.","journal-title":"J Nutr Metab"},{"issue":"7","key":"8624_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/ndt\/gfab015","volume":"36","author":"M Ugrica","year":"2021","unstructured":"Ugrica M, Bettoni C, Bourgeois S, Daryadel A, Pastor-Arroyo EM, Gehring N, et al. A chronic high phosphate intake in mice is detrimental for bone health without major renal alterations. Nephrol Dial Transpl. 2021;36(7):1183\u201391. https:\/\/doi.org\/10.1093\/ndt\/gfab015.","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"8624_CR31","doi-asserted-by":"publisher","first-page":"e0207601","DOI":"10.1371\/journal.pone.0207601","volume":"13","author":"CJ Vorland","year":"2018","unstructured":"Vorland CJ, Lachcik PJ, Aromeh LO, Moe SM, Chen NX, Hill Gallant KM. Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats. PLoS One. 2018;13(11):e0207601. https:\/\/doi.org\/10.1371\/journal.pone.0207601.","journal-title":"PLoS One"},{"issue":"2","key":"8624_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.ajkd.2013.07.012","volume":"63","author":"D Zhang","year":"2014","unstructured":"Zhang D, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Kidney Dis. 2014;63(2):198\u2013205. https:\/\/doi.org\/10.1053\/j.ajkd.2013.07.012.","journal-title":"Am J Kidney Dis"},{"key":"8624_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-030-91623-7_7","volume":"1362","author":"MC Hu","year":"2022","unstructured":"Hu MC, Moe OW. Phosphate and cellular Senescence. Adv Exp Med Biol. 2022;1362:55\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"8624_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/j.ajkd.2015.06.027","volume":"67","author":"KD Yoo","year":"2016","unstructured":"Yoo KD, Kang S, Choi Y, Yang SH, Heo NJ, Chin HJ, et al. Sex, age, and the Association of Serum Phosphorus with all-cause mortality in adults with normal kidney function. Am J Kidney Dis. 2016;67(1):79\u201388.","journal-title":"Am J Kidney Dis"},{"key":"8624_CR35","doi-asserted-by":"publisher","first-page":"102215","DOI":"10.1016\/j.arr.2024.102215","volume":"95","author":"GC Dai","year":"2024","unstructured":"Dai GC, Wang H, Ming Z, Lu PP, Li YJ, Gao YC, et al. Heterotopic mineralization (ossification or calcification) in aged musculoskeletal soft tissues: a new candidate marker for aging. Ageing Res Rev. 2024;95:102215.","journal-title":"Ageing Res Rev"},{"key":"8624_CR36","doi-asserted-by":"crossref","unstructured":"Rodelo-Haad C, Rodriguez-Ortiz ME, Garcia-Saez R, Rivas-Dominguez A, Jurado-Montoya D, Martin-Malo A, et al. The true cost of phosphate control in chronic kidney disease. Clin Kidney J. 2025;18(Suppl 1):i46\u201360.","DOI":"10.1093\/ckj\/sfae434"},{"issue":"21","key":"8624_CR37","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.3390\/nu14214477","volume":"14","author":"N Mironov","year":"2022","unstructured":"Mironov N, Haque M, Atfi A, Razzaque MS. Phosphate dysregulation and metabolic syndrome. Nutrients. 2022;14(21):4477. https:\/\/doi.org\/10.3390\/nu14214477.","journal-title":"Nutrients"},{"issue":"2","key":"8624_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.ajkd.2023.04.017","volume":"83","author":"SL Murray","year":"2024","unstructured":"Murray SL, Wolf M. Calcium and phosphate disorders: core curriculum 2024. Am J Kidney Dis. 2024;83(2):241\u201356. https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.017.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"8624_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ndt\/gfad188","volume":"39","author":"CA Wagner","year":"2024","unstructured":"Wagner CA. The basics of phosphate metabolism. Nephrol Dial Transpl. 2024;39(2):190\u2013201. https:\/\/doi.org\/10.1093\/ndt\/gfad188.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"8624_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz C, Juppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61(1):91\u2013104. https:\/\/doi.org\/10.1146\/annurev.med.051308.111339.","journal-title":"Annu Rev Med"},{"issue":"2","key":"8624_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfq498","volume":"26","author":"JM Lorenzen","year":"2011","unstructured":"Lorenzen JM, Hafer C, Faulhaber-Walter R, Kumpers P, Kielstein JT, Haller H, et al. Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrol Dial Transpl. 2011;26(2):531\u201337. https:\/\/doi.org\/10.1093\/ndt\/gfq498.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"8624_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4103\/ijn.IJN_321_17","volume":"28","author":"V Chaitanya","year":"2018","unstructured":"Chaitanya V, Devi NH, Suchitra MM, Rao P, Lakshmi BV, Kumar VS. Osteopontin, cardiovascular risk factors and carotid intima-media thickness in chronic kidney disease. Indian J Nephrol. 2018;28(5):358\u201364. https:\/\/doi.org\/10.4103\/ijn.IJN_321_17.","journal-title":"Indian J Nephrol"},{"issue":"3","key":"8624_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5551\/jat.RV17045","volume":"28","author":"OM Kuro","year":"2021","unstructured":"Kuro OM. Phosphate as a pathogen of arteriosclerosis and aging. J Atheroscler Thromb. 2021;28(3):203\u201313. https:\/\/doi.org\/10.5551\/jat.RV17045.","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"8624_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41581-018-0087-2","volume":"15","author":"M Vervloet","year":"2019","unstructured":"Vervloet M. Renal and extrarenal effects of fibroblast growth factor 23. Nat Rev Nephrol. 2019;15(2):109\u201320. https:\/\/doi.org\/10.1038\/s41581-018-0087-2.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"8624_CR45","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/ndt\/gft065","volume":"28","author":"CP Kovesdy","year":"2013","unstructured":"Kovesdy CP, Quarles LD. Fibroblast growth factor-23: what we know, what we don\u2019t know, and what we need to know. Nephrol Dial Transpl. 2013;28(9):2228\u201336.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"8624_CR46","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/sj.ki.5001813","volume":"70","author":"IC Forster","year":"2006","unstructured":"Forster IC, Hernando N, Biber J, Murer H. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int. 2006;70(9):1548\u201359. https:\/\/doi.org\/10.1038\/sj.ki.5001813.","journal-title":"Kidney Int"},{"issue":"11","key":"8624_CR47","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.3390\/nu7115492","volume":"7","author":"R Adatorwovor","year":"2015","unstructured":"Adatorwovor R, Roggenkamp K, Anderson JJ. Intakes of calcium and phosphorus and calculated calcium-to-phosphorus ratios of older adults: NHANES 2005\u20132006 data. Nutrients. 2015;7(11):9633\u201339. https:\/\/doi.org\/10.3390\/nu7115492.","journal-title":"Nutrients"},{"issue":"10","key":"8624_CR48","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3945\/jn.111.142257","volume":"141","author":"VL Fulgoni","year":"2011","unstructured":"Fulgoni VL, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients? J Nutr. 2011;141(10):1847\u201354. https:\/\/doi.org\/10.3945\/jn.111.142257.","journal-title":"J Nutr"},{"key":"8624_CR49","unstructured":"Institute of Medicine. Dietary Reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington (DC): National Academies Press (US); 1997."},{"issue":"4","key":"8624_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bone.2007.07.007","volume":"41","author":"HR Buie","year":"2007","unstructured":"Buie HR, Campbell GM, Klinck RJ, MacNeil JA, Boyd SK. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone. 2007;41(4):505\u201315. https:\/\/doi.org\/10.1016\/j.bone.2007.07.007.","journal-title":"Bone"},{"issue":"1","key":"8624_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/01495739708936692","volume":"1","author":"T Hildebrand","year":"1997","unstructured":"Hildebrand T, Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng. 1997;1(1):15\u201323. https:\/\/doi.org\/10.1080\/01495739708936692.","journal-title":"Comput Methods Biomech Biomed Eng"},{"issue":"7","key":"8624_CR52","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Min Res. 2010;25(7):1468\u201386. https:\/\/doi.org\/10.1002\/jbmr.141.","journal-title":"J Bone Min Res"},{"issue":"7","key":"8624_CR53","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","volume":"14","author":"T Hildebrand","year":"1999","unstructured":"Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Min Res. 1999;14(7):1167\u201374. https:\/\/doi.org\/10.1359\/jbmr.1999.14.7.1167.","journal-title":"J Bone Min Res"},{"issue":"1","key":"8624_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature Committee. J Bone Min Res. 2013;28(1):2\u201317. https:\/\/doi.org\/10.1002\/jbmr.1805.","journal-title":"J Bone Min Res"},{"key":"8624_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biomaterials.2015.06.039","volume":"65","author":"SW Ha","year":"2015","unstructured":"Ha SW, Jang HL, Nam KT, Beck GR Jr. Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression. Biomaterials. 2015;65:32\u201342. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.06.039.","journal-title":"Biomaterials"},{"key":"8624_CR56","doi-asserted-by":"publisher","unstructured":"Wang X, Spandidos A, Wang H, Seed B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 2012;40(D1):D1144\u20139. https:\/\/doi.org\/10.1093\/nar\/gkr1013.","DOI":"10.1093\/nar\/gkr1013"},{"issue":"4","key":"8624_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25(4):402\u201308. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"7","key":"8624_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ki.2009.522","volume":"77","author":"YJ Hsu","year":"2010","unstructured":"Hsu YJ, Dimke H, Schoeber JPH, Hsu SC, Lin SH, Chu P, et al. Testosterone increases urinary calcium excretion and inhibits expression of renal calcium transport proteins. Kidney Int. 2010;77(7):601\u201308. https:\/\/doi.org\/10.1038\/ki.2009.522.","journal-title":"Kidney Int"},{"key":"8624_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mce.2017.11.011","volume":"465","author":"R Khalil","year":"2018","unstructured":"Khalil R, Kim NR, Jardi F, Vanderschueren D, Claessens F, Decallonne B. Sex steroids and the kidney: role in renal calcium and phosphate handling. Mol Cell Endocrinol. 2018;465:61\u201372. https:\/\/doi.org\/10.1016\/j.mce.2017.11.011.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"8624_CR60","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1038\/s41598-023-34800-w","volume":"13","author":"A Bosman","year":"2023","unstructured":"Bosman A, Koek WNH, Campos-Obando N, van der Eerden BCJ, Ikram MA, Uitterlinden AG, et al. Sexual dimorphisms in serum calcium and phosphate concentrations in the Rotterdam study. Sci Rep. 2023;13(1):8310. https:\/\/doi.org\/10.1038\/s41598-023-34800-w.","journal-title":"Sci Rep"},{"issue":"2","key":"8624_CR61","doi-asserted-by":"publisher","first-page":"F328","DOI":"10.1152\/ajprenal.00584.2018","volume":"316","author":"AT Layton","year":"2019","unstructured":"Layton AT, Sullivan JC. Recent advances in sex differences in kidney function. Am J Physiol Renal Physiol. 2019;316(2):F328\u201331. https:\/\/doi.org\/10.1152\/ajprenal.00584.2018.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"8624_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI112304","volume":"77","author":"AA Portale","year":"1986","unstructured":"Portale AA, Halloran BP, Murphy MM, Morris RC Jr. Oral intake of phosphorus can determine the serum concentration of 1, 25-dihydroxyvitamin D by determining its production rate in humans. J Clin Investigation. 1986;77(1):7\u201312. https:\/\/doi.org\/10.1172\/JCI112304.","journal-title":"J Clin Investigation"},{"issue":"5","key":"8624_CR63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.jrn.2007.05.008","volume":"17","author":"CM Sullivan","year":"2007","unstructured":"Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17(5):350\u201354. https:\/\/doi.org\/10.1053\/j.jrn.2007.05.008.","journal-title":"J Ren Nutr"},{"issue":"8","key":"8624_CR64","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2215\/CJN.02830409","volume":"4","author":"RA Sherman","year":"2009","unstructured":"Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370\u201373. https:\/\/doi.org\/10.2215\/CJN.02830409.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"8624_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jn\/107.1.42","volume":"107","author":"RR Bell","year":"1977","unstructured":"Bell RR, Draper HH, Tzeng DY, Shin HK, Schmidt GR. Physiological responses of human adults to foods containing phosphate additives. J Nutr. 1977;107(1):42\u201350. https:\/\/doi.org\/10.1093\/jn\/107.1.42.","journal-title":"J Nutr"},{"issue":"3","key":"8624_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1046\/j.1525-139X.2003.16037.x","volume":"16","author":"J Uribarri","year":"2003","unstructured":"Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003;16(3):186\u201388. https:\/\/doi.org\/10.1046\/j.1525-139X.2003.16037.x.","journal-title":"Semin Dial"},{"issue":"4","key":"8624_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00223-007-9011-7","volume":"80","author":"HJ Karp","year":"2007","unstructured":"Karp HJ, Vaihia KP, Karkkainen MU, Niemisto MJ, Lamberg-Allardt CJ. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach. Calcif Tissue Int. 2007;80(4):251\u201358. https:\/\/doi.org\/10.1007\/s00223-007-9011-7.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"8624_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3164\/jcbn.40.221","volume":"40","author":"Y Tani","year":"2007","unstructured":"Tani Y, Sato T, Yamanaka-Okumura H, Yamamoto H, Arai H, Sawada N, et al. Effects of prolonged high phosphorus diet on phosphorus and calcium balance in rats. J Clin.Biochem Nutr. 2007;40(3):221\u201328. https:\/\/doi.org\/10.3164\/jcbn.40.221.","journal-title":"J Clin.Biochem Nutr"},{"issue":"7","key":"8624_CR69","doi-asserted-by":"publisher","first-page":"E526","DOI":"10.1152\/ajpendo.00234.2015","volume":"310","author":"M Abuduli","year":"2016","unstructured":"Abuduli M, Ohminami H, Otani T, Kubo H, Ueda H, Kawai Y, et al. Effects of dietary phosphate on glucose and lipid metabolism. Am J Physiol Endocrinol Metab. 2016;310(7):E526\u201338.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"8624_CR70","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11357-025-01714-6","volume":"48","author":"JL Arnst","year":"2025","unstructured":"Arnst JL, Alappan UD, Viggeswarapu M, Beck GR Jr. Sustained and reversible effects of a dietary phosphate intake on bone and mineral metabolism during aging. Geroscience. 2025;48(1):705\u201325. https:\/\/doi.org\/10.1007\/s11357-025-01714-6.","journal-title":"Geroscience"},{"issue":"9","key":"8624_CR71","doi-asserted-by":"publisher","first-page":"e2100949","DOI":"10.1002\/mnfr.202100949","volume":"66","author":"M Ugrica","year":"2022","unstructured":"Ugrica M, Gehring N, Giesbertz P, Pastor-Arroyo EM, Daniel H, Wagner CA, et al. Chronic high phosphate intake in mice affects macronutrient utilization and body composition. Mol Nutr Food Res. 2022;66(9):e2100949.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"8624_CR72","doi-asserted-by":"publisher","first-page":"e0195427","DOI":"10.1371\/journal.pone.0195427","volume":"13","author":"L Kagi","year":"2018","unstructured":"Kagi L, Bettoni C, Pastor-Arroyo EM, Schnitzbauer U, Hernando N, Wagner CA. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1, 25(OH)2D3. PLoS One. 2018;13(5):e0195427. https:\/\/doi.org\/10.1371\/journal.pone.0195427.","journal-title":"PLoS One"},{"issue":"2","key":"8624_CR73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1523-1755.2001.060002412.x","volume":"60","author":"KI Miyamoto","year":"2001","unstructured":"Miyamoto KI, Itho M. Transcriptional regulation of the NPT2 gene by dietary phosphate. Kidney Int. 2001;60(2):412\u201315. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.060002412.x.","journal-title":"Kidney Int"},{"key":"8624_CR74","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fphar.2020.01273","volume":"11","author":"J Maique","year":"2020","unstructured":"Maique J, Flores B, Shi M, Shepard S, Zhou Z, Yan S, et al. High phosphate induces and Klotho attenuates kidney epithelial Senescence and fibrosis. Front Pharmacol. 2020;11:1273.","journal-title":"Front Pharmacol"},{"issue":"3","key":"8624_CR75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3164\/jcbn.2007025","volume":"41","author":"H Matsuzaki","year":"2007","unstructured":"Matsuzaki H, Katsumata S, Uehara M, Suzuki K, Miwa M. High-phosphorus diet induces osteopontin expression of renal tubules in rats. J Clin Biochem Nutr. 2007;41(3):179\u201383. https:\/\/doi.org\/10.3164\/jcbn.2007025.","journal-title":"J Clin Biochem Nutr"},{"issue":"9","key":"8624_CR76","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.34067\/KID.0007352021","volume":"3","author":"JR Stubbs","year":"2022","unstructured":"Stubbs JR, Zhang S, Jansson KP, Fields TA, Boulanger J, Liu S, et al. Critical role of osteopontin in maintaining urinary phosphate solubility in CKD. Kidney360. 2022;3(9):1578\u201389. https:\/\/doi.org\/10.34067\/KID.0007352021.","journal-title":"Kidney360"},{"issue":"2","key":"8624_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.ackd.2011.01.005","volume":"18","author":"J Blaine","year":"2011","unstructured":"Blaine J, Weinman EJ, Cunningham R. The regulation of renal phosphate transport. Adv Chronic Kidney Dis. 2011;18(2):77\u201384. https:\/\/doi.org\/10.1053\/j.ackd.2011.01.005.","journal-title":"Adv Chronic Kidney Dis"},{"key":"8624_CR78","doi-asserted-by":"crossref","unstructured":"Richter B, Kapanadze T, Weingartner N, Walter S, Vogt I, Grund A, et al. High phosphate-induced progressive proximal tubular injury is associated with the activation of Stat3\/Kim-1 signaling pathway and macrophage recruitment. Faseb J. 2022;36(7):e22407.","DOI":"10.1096\/fj.202200167RR"},{"issue":"6","key":"8624_CR79","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00223-019-00525-0","volume":"104","author":"S Fukuda-Tatano","year":"2019","unstructured":"Fukuda-Tatano S, Yamamoto H, Nakahashi O, Yoshikawa R, Hayashi M, Kishimoto M, et al. Regulation of \u03b1-Klotho expression by dietary phosphate during growth periods. Calcif Tissue Int. 2019;104(6):667\u201378. https:\/\/doi.org\/10.1007\/s00223-019-00525-0.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"8624_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1525-139X.2006.00169.x","volume":"19","author":"VP Persy","year":"2006","unstructured":"Persy VP, Behets GJ, Bervoets AR, De Broe ME, D\u2019Haese PC. Lanthanum: a safe phosphate binder. Semin Dial. 2006;19(3):195\u201399. https:\/\/doi.org\/10.1111\/j.1525-139X.2006.00169.x.","journal-title":"Semin Dial"},{"issue":"12","key":"8624_CR81","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/nep.12864","volume":"21","author":"AJ Hutchison","year":"2016","unstructured":"Hutchison AJ, Wilson RJ, Garafola S, Copley JB. Lanthanum carbonate: safety data after 10 years. Nephrology (Carlton). 2016;21(12):987\u201394. https:\/\/doi.org\/10.1111\/nep.12864.","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"8624_CR82","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2215\/CJN.04741107","volume":"3","author":"R Mehrotra","year":"2008","unstructured":"Mehrotra R, Martin KJ, Fishbane S, Sprague SM, Zeig S, Anger M, et al. Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study. Clin J Am Soc Nephrol. 2008;3(5):1437\u201345. https:\/\/doi.org\/10.2215\/CJN.04741107.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"8624_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2369-14-29","volume":"14","author":"J Xu","year":"2013","unstructured":"Xu J, Zhang YX, Yu XQ, Liu ZH, Wang LN, Chen JH, et al. Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China. BMC Nephrol. 2013;14(1):29. https:\/\/doi.org\/10.1186\/1471-2369-14-29.","journal-title":"BMC Nephrol"},{"issue":"4","key":"8624_CR84","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0253-7613.56074","volume":"41","author":"PT Scaria","year":"2009","unstructured":"Scaria PT, Gangadhar R, Pisharody R. Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease. Indian J Pharmacol. 2009;41(4):187\u201391. https:\/\/doi.org\/10.4103\/0253-7613.56074.","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"8624_CR85","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1345\/aph.1G224","volume":"40","author":"MS Joy","year":"2006","unstructured":"Joy MS, Kshirsagar A, Candiani C, Brooks T, Hudson JQ. Lanthanum carbonate. Ann Pharmacother. 2006;40(2):234\u201340. https:\/\/doi.org\/10.1345\/aph.1G224.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"8624_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/0929867324666170509125840","volume":"25","author":"J Aaseth","year":"2018","unstructured":"Aaseth J, Bjorke-Monsen AL. Lanthanum carbonate - a new phosphate binding drug in advanced renal failure. Curr Med Chem. 2018;25(1):113\u201317. https:\/\/doi.org\/10.2174\/0929867324666170509125840.","journal-title":"Curr Med Chem"},{"issue":"1","key":"8624_CR87","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1744-9987.2007.00541.x","volume":"12","author":"T Shigematsu","year":"2008","unstructured":"Shigematsu T, Lanthanum Carbonate Research G. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial. 2008;12(1):55\u201361. https:\/\/doi.org\/10.1111\/j.1744-9987.2007.00541.x.","journal-title":"Ther Apher Dial"},{"issue":"2","key":"8624_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/0886022X.2011.552821","volume":"33","author":"SJP Damment","year":"2011","unstructured":"Damment SJP. Pharmacology of the phosphate binder, lanthanum carbonate. Ren Fail. 2011;33(2):217\u201324. https:\/\/doi.org\/10.3109\/0886022X.2011.552821.","journal-title":"Ren Fail"},{"issue":"8","key":"8624_CR89","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","volume":"26","author":"E Gonzalez-Parra","year":"2011","unstructured":"Gonzalez-Parra E, Gonzalez-Casaus ML, Galan A, Martinez-Calero A, Navas V, Rodriguez M, et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transpl. 2011;26(8):2567\u201371.","journal-title":"Nephrol Dial Transpl"},{"issue":"07","key":"8624_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5414\/CN107764","volume":"80","author":"S Soriano","year":"2013","unstructured":"Soriano S, Ojeda R, Rodriguez M, Almaden Y, Rodriguez M, Martin-Malo A, et al. The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients. Clin Nephrol. 2013;80(07):17\u201322. https:\/\/doi.org\/10.5414\/CN107764.","journal-title":"Clin Nephrol"},{"issue":"1","key":"8624_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2369-15-71","volume":"15","author":"P Urena-Torres","year":"2014","unstructured":"Urena-Torres P, Prie D, Keddad K, Preston P, Wilde P, Wan H, et al. Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial. BMC Nephrol. 2014;15(1):71. https:\/\/doi.org\/10.1186\/1471-2369-15-71.","journal-title":"BMC Nephrol"},{"issue":"2","key":"8624_CR92","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transpl. 2011;26(2):584\u201391.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"8624_CR93","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2215\/CJN.09250912","volume":"8","author":"T Isakova","year":"2013","unstructured":"Isakova T, Barchi-Chung A, Enfield G, Smith K, Vargas G, Houston J, et al. Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clin J Am Soc Nephrol. 2013;8(6):1009\u201318.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"8624_CR94","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.ekir.2018.03.011","volume":"3","author":"CP Kovesdy","year":"2018","unstructured":"Kovesdy CP, Lu JL, Wall BM, Gyamlani G, Naseer A, Wallick A, et al. Changes with lanthanum carbonate, calcium acetate, and phosphorus restriction in CKD: a randomized controlled trial. Kidney Int Rep. 2018;3(4):897\u2013904.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"8624_CR95","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1159\/000488700","volume":"43","author":"F Wang","year":"2018","unstructured":"Wang F, Lu X, Zhang J, Xiong R, Li H, Wang S. Effect of lanthanum carbonate on all-cause mortality in patients receiving maintenance hemodialysis: a meta-analysis of randomized controlled Trials. Kidney Blood Press Res. 2018;43(2):536\u201344. https:\/\/doi.org\/10.1159\/000488700.","journal-title":"Kidney Blood Press Res"},{"key":"8624_CR96","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","volume":"63","author":"PC D\u2019Haese","year":"2003","unstructured":"D\u2019Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol\u2122) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int. 2003;63:S73\u20138. https:\/\/doi.org\/10.1046\/j.1523-1755.63.s85.18.x.","journal-title":"Kidney Int"},{"key":"8624_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/IJNRD.S15466","volume":"5","author":"T Shigematsu","year":"2012","unstructured":"Shigematsu T, Nakashima Y, Ohya M, Tatsuta K, Koreeda D, Yoshimoto W, et al. The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients. Int J Nephrol Renovasc Dis. 2012;5:81\u201389.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"8624_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","volume":"22","author":"BC Silva","year":"2015","unstructured":"Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol. 2015;22:41\u201350. https:\/\/doi.org\/10.1016\/j.coph.2015.03.005.","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"8624_CR99","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Urena Torres P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 2016;90(6):1184\u201390. https:\/\/doi.org\/10.1016\/j.kint.2016.06.041.","journal-title":"Kidney Int"},{"key":"8624_CR100","first-page":"183","volume":"9","author":"MS Calvo","year":"1994","unstructured":"Calvo MS. The effects of high phosphorus intake on calcium homeostasis. Adv Nutr Res. 1994;9:183\u2013207.","journal-title":"Adv Nutr Res"},{"issue":"1","key":"8624_CR101","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","volume":"10","author":"PP Centeno","year":"2019","unstructured":"Centeno PP, Herberger A, Mun HC, Tu C, Nemeth EF, Chang W, et al. Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion. Nat Commun. 2019;10(1):4693. https:\/\/doi.org\/10.1038\/s41467-019-12399-9.","journal-title":"Nat Commun"},{"issue":"6","key":"8624_CR102","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1046\/j.1523-1755.1998.00221.x","volume":"54","author":"AL de Francisco","year":"1998","unstructured":"de Francisco AL, Cobo MA, Setien MA, Rodrigo E, Fresnedo GF, Unzueta MT, et al. Effect of serum phosphate on parathyroid hormone secretion during hemodialysis. Kidney Int. 1998;54(6):2140\u201345.","journal-title":"Kidney Int"},{"issue":"5","key":"8624_CR103","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.V115903","volume":"11","author":"JI Chin","year":"2000","unstructured":"Chin JI, Miller SC, Wada M, Nagano N, Nemeth EF, Fox J. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol. 2000;11(5):903\u201311. https:\/\/doi.org\/10.1681\/ASN.V115903.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"8624_CR104","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","volume":"57","author":"M Wada","year":"2000","unstructured":"Wada M, Nagano N, Furuya Y, Chin J, Nemeth EF, Fox J. Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney Int. 2000;57(1):50\u201358. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00837.x.","journal-title":"Kidney Int"},{"issue":"1","key":"8624_CR105","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","volume":"63","author":"JS Lindberg","year":"2003","unstructured":"Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, et al. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney Int. 2003;63(1):248\u201354.","journal-title":"Kidney Int"},{"issue":"3","key":"8624_CR106","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","volume":"14","author":"LD Quarles","year":"2003","unstructured":"Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, et al. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol. 2003;14(3):575\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"8624_CR107","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2369-14-112","volume":"14","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, et al. Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study. BMC Nephrol. 2013;14(1):112. https:\/\/doi.org\/10.1186\/1471-2369-14-112.","journal-title":"BMC Nephrol"},{"issue":"15","key":"8624_CR108","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516\u201325.","journal-title":"N Engl J Med"},{"issue":"2","key":"8624_CR109","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/08998280.2005.11928062","volume":"18","author":"G Poon","year":"2005","unstructured":"Poon G. Cinacalcet hydrochloride (Sensipar). Proc (Bayl Univ Med Cent). 2005;18(2):181\u201384. https:\/\/doi.org\/10.1080\/08998280.2005.11928062.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"11","key":"8624_CR110","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1172\/JCI106432","volume":"49","author":"E Reiss","year":"1970","unstructured":"Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest. 1970;49(11):2146\u201349. https:\/\/doi.org\/10.1172\/JCI106432.","journal-title":"J Clin Invest"},{"issue":"4","key":"8624_CR111","doi-asserted-by":"publisher","first-page":"E729","DOI":"10.1152\/ajpendo.00065.2005","volume":"289","author":"DR Martin","year":"2005","unstructured":"Martin DR, Ritter CS, Slatopolsky E, Brown AJ. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab. 2005;289(4):E729\u201334. https:\/\/doi.org\/10.1152\/ajpendo.00065.2005.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"8624_CR112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000487546","volume":"139","author":"P Greeviroj","year":"2018","unstructured":"Greeviroj P, Kitrungphaiboon T, Katavetin P, Praditpornsilpa K, Eiam-Ong S, Jaber BL, et al. Cinacalcet for treatment of chronic kidney disease-mineral and bone disorder: a meta-analysis of randomized controlled Trials. Nephron. 2018;139(3):197\u2013210. https:\/\/doi.org\/10.1159\/000487546.","journal-title":"Nephron"},{"key":"8624_CR113","doi-asserted-by":"crossref","unstructured":"Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, Lane N, et al. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol. 2010;298(6):F1315\u201322.","DOI":"10.1152\/ajprenal.00552.2009"},{"issue":"2","key":"8624_CR114","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/ndt\/gfr384","volume":"27","author":"M Koizumi","year":"2012","unstructured":"Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transpl. 2012;27(2):784\u201390. https:\/\/doi.org\/10.1093\/ndt\/gfr384.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"8624_CR115","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, et al. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of Cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation. 2015;132(1):27\u201339. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013876.","journal-title":"Circulation"},{"issue":"2","key":"8624_CR116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.23876\/j.krcp.19.041","volume":"38","author":"F Abbas","year":"2019","unstructured":"Abbas F, Coyne DW. Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease. Kidney Res Clin Pract. 2019;38(2):141\u201344. https:\/\/doi.org\/10.23876\/j.krcp.19.041.","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"8624_CR117","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","volume":"53","author":"M Chonchol","year":"2009","unstructured":"Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco ALM, Jolly S, et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2009;53(2):197\u2013207. https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.021.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"8624_CR118","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/ijms20112800","volume":"20","author":"CM Zheng","year":"2019","unstructured":"Zheng CM, Hsu YH, Wu CC, Lu CL, Liu WC, Zheng JQ, et al. Osteoclast-released wnt-10b underlies Cinacalcet related bone improvement in chronic kidney disease. Int J Mol Sci. 2019;20(11):2800. https:\/\/doi.org\/10.3390\/ijms20112800.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8624_CR119","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jbmr.4459","volume":"37","author":"HW Chiu","year":"2020","unstructured":"Chiu HW, Hou YC, Lu CL, Lu KC, Liu WC, Shyu JF, et al. Cinacalcet improves bone parameters through regulation of osteoclast endoplasmic reticulum stress, autophagy, and apoptotic pathways in chronic kidney disease\u2013mineral and bone disorder. J Bone Mineral Res. 2020;37(2):215\u201325. https:\/\/doi.org\/10.1002\/jbmr.4459.","journal-title":"J Bone Mineral Res"},{"key":"8624_CR120","doi-asserted-by":"publisher","first-page":"116340","DOI":"10.1016\/j.bone.2022.116340","volume":"157","author":"EA Swallow","year":"2022","unstructured":"Swallow EA, Metzger CE, Newman CL, Chen NX, Moe SM, Allen MR. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease. Bone. 2022;157:116340. https:\/\/doi.org\/10.1016\/j.bone.2022.116340.","journal-title":"Bone"},{"issue":"3","key":"8624_CR121","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3945\/ajcn.113.067199","volume":"99","author":"JF Aloia","year":"2014","unstructured":"Aloia JF, Dhaliwal R, Shieh A, Mikhail M, Fazzari M, Ragolia L, et al. Vitamin D supplementation increases calcium absorption without a threshold effect. Am J Clin Nutr. 2014;99(3):624\u201331.","journal-title":"Am J Clin Nutr"},{"issue":"1\u20132","key":"8624_CR122","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2011.05.038","volume":"347","author":"S Christakos","year":"2011","unstructured":"Christakos S, Dhawan P, Porta A, Mady LJ, Seth T. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347(1\u20132):25\u201329. https:\/\/doi.org\/10.1016\/j.mce.2011.05.038.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"8624_CR123","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1056\/NEJMe2205993","volume":"387","author":"SR Cummings","year":"2022","unstructured":"Cummings SR, Rosen C. VITAL findings \u2014 a decisive verdict on vitamin D supplementation. N Engl J Med. 2022;387(4):368\u201370. https:\/\/doi.org\/10.1056\/NEJMe2205993.","journal-title":"N Engl J Med"},{"issue":"4","key":"8624_CR124","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3945\/jn.109.118539","volume":"140","author":"RL Bailey","year":"2010","unstructured":"Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010;140(4):817\u201322. https:\/\/doi.org\/10.3945\/jn.109.118539.","journal-title":"J Nutr"},{"issue":"1","key":"8624_CR125","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-018-2231-z","volume":"471","author":"G Jacquillet","year":"2019","unstructured":"Jacquillet G, Unwin RJ. Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflugers Arch - Eur J Physiol. 2019;471(1):83\u201398. https:\/\/doi.org\/10.1007\/s00424-018-2231-z.","journal-title":"Pflugers Arch - Eur J Physiol"},{"issue":"6","key":"8624_CR126","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ki.2013.526","volume":"85","author":"D Spichtig","year":"2014","unstructured":"Spichtig D, Zhang H, Mohebbi N, Pavik I, Petzold K, Stange G, et al. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease. Kidney Int. 2014;85(6):1340\u201350. https:\/\/doi.org\/10.1038\/ki.2013.526.","journal-title":"Kidney Int"},{"issue":"8","key":"8624_CR127","doi-asserted-by":"publisher","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","volume":"8","author":"C Zanchi","year":"2013","unstructured":"Zanchi C, Locatelli M, Benigni A, Corna D, Tomasoni S, Rottoli D, et al. Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor. PLoS One. 2013;8(8):e70775. https:\/\/doi.org\/10.1371\/journal.pone.0070775.","journal-title":"PLoS One"},{"issue":"1","key":"8624_CR128","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41598-017-02709-w","volume":"7","author":"ER Smith","year":"2017","unstructured":"Smith ER, Tan SJ, Holt SG, Hewitson TD. FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts. Sci Rep. 2017;7(1):3345. https:\/\/doi.org\/10.1038\/s41598-017-02709-w.","journal-title":"Sci Rep"},{"issue":"4","key":"8624_CR129","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2016.05.027","volume":"90","author":"E Letavernier","year":"2016","unstructured":"Letavernier E, Verrier C, Goussard F, Perez J, Huguet L, Haymann JP, et al. Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease. Kidney Int. 2016;90(4):809\u201317.","journal-title":"Kidney Int"},{"issue":"4","key":"8624_CR130","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/jbmr.2089","volume":"29","author":"SM Moe","year":"2014","unstructured":"Moe SM, Chen NX, Newman CL, Gattone VH 2nd, Organ JM, Chen X, et al. A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Min Res. 2014;29(4):902\u201310.","journal-title":"J Bone Min Res"},{"issue":"1","key":"8624_CR131","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1475-2891-13-114","volume":"13","author":"KJ Lee","year":"2014","unstructured":"Lee KJ, Kim KS, Kim HN, Seo JA, Song SW. Association between dietary calcium and phosphorus intakes, dietary calcium\/phosphorus ratio and bone mass in the Korean population. Nutr J. 2014;13(1):114. https:\/\/doi.org\/10.1186\/1475-2891-13-114.","journal-title":"Nutr J"},{"issue":"7","key":"8624_CR132","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1210\/jc.2012-1027","volume":"97","author":"S Khosla","year":"2012","unstructured":"Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, et al. Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab. 2012;97(7):2272\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"8624_CR133","doi-asserted-by":"publisher","first-page":"118681","DOI":"10.1016\/j.lfs.2020.118681","volume":"264","author":"A Oryan","year":"2021","unstructured":"Oryan A, Sahvieh S. Effects of bisphosphonates on osteoporosis: focus on zoledronate. Life Sci. 2021;264:118681. https:\/\/doi.org\/10.1016\/j.lfs.2020.118681.","journal-title":"Life Sci"},{"issue":"1","key":"8624_CR134","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/boneres.2017.2","volume":"5","author":"A Takakura","year":"2017","unstructured":"Takakura A, Lee JW, Hirano K, Isogai Y, Ishizuya T, Takao-Kawabata R, et al. Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats. Bone Res. 2017;5(1):17002. https:\/\/doi.org\/10.1038\/boneres.2017.2.","journal-title":"Bone Res"},{"issue":"4","key":"8624_CR135","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bone.2012.07.004","volume":"51","author":"NR Portero-Muzy","year":"2012","unstructured":"Portero-Muzy NR, Chavassieux PM, Bouxsein ML, Gineyts E, Garnero P, Chapurlat RD. Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes. Bone. 2012;51(4):714\u201319. https:\/\/doi.org\/10.1016\/j.bone.2012.07.004.","journal-title":"Bone"},{"key":"8624_CR136","doi-asserted-by":"publisher","unstructured":"Daroszewska A, Rose L, Sarsam N, Charlesworth G, Prior A, Rose K, et al. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget\u2019s disease. Dis Model Mech. 2018;11(9). https:\/\/doi.org\/10.1242\/dmm.035576.","DOI":"10.1242\/dmm.035576"},{"issue":"12","key":"8624_CR137","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1007\/s00198-016-3701-9","volume":"27","author":"MW Aref","year":"2016","unstructured":"Aref MW, McNerny EM, Brown D, Jepsen KJ, Allen MR. Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes. Osteoporos Int. 2016;27(12):3637\u201343. https:\/\/doi.org\/10.1007\/s00198-016-3701-9.","journal-title":"Osteoporos Int"},{"issue":"4","key":"8624_CR138","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00198-012-2103-x","volume":"24","author":"MR Allen","year":"2013","unstructured":"Allen MR, Chen NX, Gattone VH 2nd, Chen X, Carr AJ, LeBlanc P, et al. Skeletal effects of zoledronic acid in an animal model of chronic kidney disease. Osteoporos Int. 2013;24(4):1471\u201381. https:\/\/doi.org\/10.1007\/s00198-012-2103-x.","journal-title":"Osteoporos Int"},{"issue":"100","key":"8624_CR139","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bone.2014.06.023","volume":"66","author":"MT Haider","year":"2014","unstructured":"Haider MT, Holen I, Dear TN, Hunter K, Brown HK. Modifying the osteoblastic niche with zoledronic acid in vivo\u2014potential implications for breast cancer bone metastasis. Bone. 2014;66(100):240\u201350. https:\/\/doi.org\/10.1016\/j.bone.2014.06.023.","journal-title":"Bone"},{"issue":"5","key":"8624_CR140","doi-asserted-by":"publisher","first-page":"e19389","DOI":"10.1371\/journal.pone.0019389","volume":"6","author":"TT Hung","year":"2011","unstructured":"Hung TT, Chan J, Russell PJ, Power CA. Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model. PLoS One. 2011;6(5):e19389. https:\/\/doi.org\/10.1371\/journal.pone.0019389.","journal-title":"PLoS One"},{"issue":"18","key":"8624_CR141","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1158\/1078-0432.CCR-09-0426","volume":"15","author":"S Pozzi","year":"2009","unstructured":"Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009;15(18):5829\u201339.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"8624_CR142","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/jbmr.1784","volume":"28","author":"S Hansen","year":"2013","unstructured":"Hansen S, Hauge EM, Beck Jensen JE, Brixen K. Differing effects of PTH 1\u201334, PTH 1\u201384, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Min Res. 2013;28(4):736\u201345. https:\/\/doi.org\/10.1002\/jbmr.1784.","journal-title":"J Bone Min Res"},{"key":"8624_CR143","doi-asserted-by":"publisher","unstructured":"Piemontese M, Almeida M, Robling AG, Kim HN, Xiong J, Thostenson JD, et al. Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight. 2017;2(17). https:\/\/doi.org\/10.1172\/jci.insight.93771.","DOI":"10.1172\/jci.insight.93771"},{"issue":"9727","key":"8624_CR144","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","volume":"375","author":"RM Zebaze","year":"2010","unstructured":"Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010;375(9727):1729\u201336.","journal-title":"Lancet"},{"issue":"5","key":"8624_CR145","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S8756-3282(97)00173-7","volume":"21","author":"YN Yeni","year":"1997","unstructured":"Yeni YN, Brown CU, Wang Z, Norman TL. The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997;21(5):453\u201359. https:\/\/doi.org\/10.1016\/S8756-3282(97)00173-7.","journal-title":"Bone"},{"issue":"6","key":"8624_CR146","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/jbmr.2167","volume":"29","author":"Y Bala","year":"2014","unstructured":"Bala Y, Zebaze R, Ghasem-Zadeh A, Atkinson EJ, Iuliano S, Peterson JM, et al. Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Min Res. 2014;29(6):1356\u201362.","journal-title":"J Bone Min Res"},{"key":"8624_CR147","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bonekey.2016.77","volume":"5","author":"\u00c5 Bjornerem","year":"2016","unstructured":"Bjornerem \u00c5. The clinical contribution of cortical porosity to fragility fractures. BoneKEy Rep. 2016;5:846. https:\/\/doi.org\/10.1038\/bonekey.2016.77.","journal-title":"BoneKEy Rep"},{"key":"8624_CR148","doi-asserted-by":"publisher","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","volume":"139","author":"MJ Rogers","year":"2020","unstructured":"Rogers MJ, Monkkonen J, Munoz MA. Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton. Bone. 2020;139:115493. https:\/\/doi.org\/10.1016\/j.bone.2020.115493.","journal-title":"Bone"},{"issue":"1","key":"8624_CR149","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-018-0074-9","volume":"38","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Okinaga T, Hikiji H, Ariyoshi W, Yoshiga D, Habu M, et al. Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen. 2018;38(1):16. https:\/\/doi.org\/10.1186\/s41232-018-0074-9.","journal-title":"Inflamm Regen"},{"issue":"8","key":"8624_CR150","doi-asserted-by":"publisher","first-page":"e1338238","DOI":"10.1080\/2162402X.2017.1338238","volume":"6","author":"D Sarhan","year":"2017","unstructured":"Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, et al. Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology. 2017;6(8):e1338238. https:\/\/doi.org\/10.1080\/2162402X.2017.1338238.","journal-title":"Oncoimmunology"},{"issue":"1","key":"8624_CR151","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00204-017-2048-0","volume":"92","author":"L Cheng","year":"2018","unstructured":"Cheng L, Ge M, Lan Z, Ma Z, Chi W, Kuang W, et al. Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018;92(1):469\u201385. https:\/\/doi.org\/10.1007\/s00204-017-2048-0.","journal-title":"Arch Toxicol"},{"issue":"1","key":"8624_CR152","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1186\/s12885-024-13284-5","volume":"24","author":"Z Wang","year":"2024","unstructured":"Wang Z, Su X, Shi D, Wei L. Evaluate the renal system damage caused by zoledronic acid: a comprehensive analysis of adverse events from FAERS. BMC Cancer. 2024;24(1):1520. https:\/\/doi.org\/10.1186\/s12885-024-13284-5.","journal-title":"BMC Cancer"},{"issue":"Suppl S2","key":"8624_CR153","doi-asserted-by":"publisher","first-page":"V2","DOI":"10.1359\/jbmr.07s216","volume":"22","author":"PW Jurutka","year":"2007","unstructured":"Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Min Res. 2007;22(Suppl S2):V2\u201310. https:\/\/doi.org\/10.1359\/jbmr.07s216.","journal-title":"J Bone Min Res"},{"issue":"12","key":"8624_CR154","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1172\/JCI29463","volume":"116","author":"R Masuyama","year":"2006","unstructured":"Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest. 2006;116(12):3150\u201359. https:\/\/doi.org\/10.1172\/JCI29463.","journal-title":"J Clin Invest"},{"key":"8624_CR155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fphys.2014.00137","volume":"5","author":"J van de Peppel","year":"2014","unstructured":"van de Peppel J, van Leeuwen JPTM. Vitamin D and gene networks in human osteoblasts. Front Physiol. 2014;5:137. https:\/\/doi.org\/10.3389\/fphys.2014.00137.","journal-title":"Front Physiol"},{"issue":"3","key":"8624_CR156","doi-asserted-by":"publisher","first-page":"e0191706","DOI":"10.1371\/journal.pone.0191706","volume":"13","author":"H Sugiura","year":"2018","unstructured":"Sugiura H, Matsushita A, Futaya M, Teraoka A, Akiyama KI, Usui N, et al. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model. PLoS One. 2018;13(3):e0191706. https:\/\/doi.org\/10.1371\/journal.pone.0191706.","journal-title":"PLoS One"},{"issue":"5","key":"8624_CR157","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1248\/bpb.b14-00276","volume":"38","author":"Y Masuda","year":"2015","unstructured":"Masuda Y, Ohta H, Morita Y, Nakayama Y, Miyake A, Itoh N, et al. Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice. Biol Pharm Bull. 2015;38(5):687\u201393.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"8624_CR158","doi-asserted-by":"publisher","first-page":"e0264743","DOI":"10.1371\/journal.pone.0264743","volume":"17","author":"P Kumar","year":"2022","unstructured":"Kumar P, Liu Y, Shen Y, Maher JJ, Cingolani F, Czaja MJ. Mouse liver injury induces hepatic macrophage FGF23 production. PLoS One. 2022;17(3):e0264743. https:\/\/doi.org\/10.1371\/journal.pone.0264743.","journal-title":"PLoS One"},{"issue":"1","key":"8624_CR159","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/1873-3468.12040","volume":"590","author":"X Han","year":"2016","unstructured":"Han X, Li L, Yang J, King G, Xiao Z, Quarles LD. Counter-regulatory paracrine actions of FGF-23 and 1, 25(OH)2 D in macrophages. FEBS Lett. 2016;590(1):53\u201367. https:\/\/doi.org\/10.1002\/1873-3468.12040.","journal-title":"FEBS Lett"},{"issue":"1","key":"8624_CR160","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/ijms27010408","volume":"27","author":"C Novillo-Sarmiento","year":"2025","unstructured":"Novillo-Sarmiento C, Garcia-Saez RM, Rivas-Dominguez A, Torralba-Duque A, Rodelo-Haad C, Rodriguez-Ortiz ME, et al. Phosphate and inflammation in health and kidney disease. Int J Mol Sci. 2025;27(1):408. https:\/\/doi.org\/10.3390\/ijms27010408.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8624_CR161","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/antiox14020144","volume":"14","author":"ESAC Simoes","year":"2025","unstructured":"Simoes ESAC. Oxidative stress in renal health. Antioxidants (Basel). 2025;14(2):144. https:\/\/doi.org\/10.3390\/antiox14020144.","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"8624_CR162","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2215\/CJN.02420409","volume":"4","author":"JF Navarro-Gonzalez","year":"2009","unstructured":"Navarro-Gonzalez JF, Mora-Fernandez C, Muros M, Herrera H, Garcia J. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol. 2009;4(10):1646\u201354. https:\/\/doi.org\/10.2215\/CJN.02420409.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"8624_CR163","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/antiox14040461","volume":"14","author":"MA Lacerda-Abreu","year":"2025","unstructured":"Lacerda-Abreu MA, Meyer-Fernandes JR. Hyperphosphataemia and NADPH oxidase regulation in pathophysiological processes: implications for oxidative stress and disease progression. Antioxidants (Basel). 2025;14(4):461. https:\/\/doi.org\/10.3390\/antiox14040461.","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"8624_CR164","doi-asserted-by":"publisher","first-page":"F1285","DOI":"10.1152\/ajprenal.00057.2014","volume":"306","author":"SR Khan","year":"2014","unstructured":"Khan SR, Joshi S, Wang W, Peck AB. Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria. Am J Physiol Renal Physiol. 2014;306(11):F1285\u201395. https:\/\/doi.org\/10.1152\/ajprenal.00057.2014.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"8624_CR165","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-020-00392-1","volume":"17","author":"SR Khan","year":"2021","unstructured":"Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall\u2019s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 2021;17(6):417\u201333. https:\/\/doi.org\/10.1038\/s41581-020-00392-1.","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08624-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:30Z","timestamp":1792425750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8624"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08624-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1318"}}